Relationship of serum trimethylamine N-oxide (TMAO) levels with early atherosclerosis in humans

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Randrianarisoa, Elko ^a   Lehn Stefan, Angela ^a,b   Wang, Xiaolin ^c   Hoene, Miriam ^a   Peter, Andreas ^a,b   Heinzmann, Silke S ^b,d   Zhao, Xinjie ^c   Königsrainer, Ingmar ^a   Königsrainer, Alfred ^a   Balletshofer, Bernd ^a   Machann, Jürgen ^a,b   Schick, Fritz ^a,b   Fritsche, Andreas ^a,b   Hring, Hans Ulrich ^a,b   Xu, Guowang ^c   Lehmann, Rainer ^a,b   Stefan, Norbert ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLAMINE; TRIMETHYLOXAMINE;

ADULT; ATHEROSCLEROSIS; BLOOD; CLINICAL TRIAL; FEMALE; HUMAN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS;

ADIPOSITY; ADULT; ATHEROSCLEROSIS; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; METHYLAMINES; MIDDLE AGED; OXIDATIVE STRESS;

EID: 84971299234     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26745     Document Type: Article

References (40)

1. Loscalzo, J. Gut microbiota, the genome, and diet in atherogenesis. N Engl J Med. 25(368), 1647-1649 (2013
2. Tang, W. H., et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 368, 1575-1584 (2013
3. Wang, Z., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57-63 (2011
4. Koeth, R. A., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 19, 576-585 (2013
5. Koeth, R. A., et al. γ -Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab. 20, 799-812 (2014
6. Stubbs, J. R., et al. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. J Am Soc Nephrol. 27, 305-313 (2016
7. Kaysen, G. A., et al. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis. J Ren Nutr. 25, 351-356 (2015
8. Mueller, D. M., et al. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. Atherosclerosis. 243, 638-644 (2015
9. Bennett, B. J., et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 17, 49-60 (2013
10. Warrier, M., et al. The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance. Cell Rep. pii: S2211-1247(14)01065-1. (2015
11. Schugar, R. C., & Brown, J. M. Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis. Curr Opin Lipidol. 26, 426-431 (2015
12. Shih, D. M., et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. J Lipid Res. 56, 22-37 (2015
13. Miao, J., et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat Commun. 6, 6498 (2015
14. Artinian, N. T., et al. American Heart Association Prevention Committee of the Council on Cardiovascular Nursing. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation 122, 406-441 (2010
15. Li, G., et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2, 474-480 (2014
16. Lehmann, R., et al. Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care 36, 2331-2338 (2013
17. Stefan, N., et al. A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. Diabetologia 58, 2877-84 (2015
18. Chalasani, N., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005-2023 (2012
19. Peter, A., et al. PNPLA3 variant I148M is associated with altered hepatic lipid composition in humans. Diabetologia 57, 2103-2107 (2014
20. Baecke, J. A., Burema, J., & Frijters, J. E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 36, 936-942 (1982
21. Stefan, N., et al. Inhibition of 11β -HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, doubleblind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2, 406-416 (2014
22. Szczepaniak, L. S., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 288, E462-468 (2005
23. Matsuda, M., & DeFronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470 (1999
24. Matthews, D. R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985
25. Balletshofer, B. M., et al. Early carotid atherosclerosis in overweight non-diabetic individuals is associated with subclinical chronic inflammation independent of underlying insulin resistance. Horm Metab Res. 37, 331-335 (2005
26. Levey, A. S., et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values, Clin. Chem. 53, 766-772 (2007
27. Wang, Z., et al. Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. Anal Biochem. 455, 35-40 (2014
28. Mozaffarian, D., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131, e29-322 (2015
29. Tang, W. H., & Hazen, S. L. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest. 124, 4204-4211 (2014
30. Ufnal, M., Zadlo, A., & Ostaszewski, R. TMAO: A small molecule of great expectations. Nutrition. 31, 1317-1323 (2015
31. Gao, X., et al. Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. J Biosci Bioeng. 118, 476-481 (2014
32. Saltiel, A.R., & Kahn, C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806 (2001
33. Semple, R. K. EJE PRIZE 2015: How does insulin resistance arise, and how does it cause disease? Human genetic lessons. Eur J Endocrinol. 174, R209-223 (2016
34. Boutagy, N. E., et al. Short-term high-fat diet increases postprandial trimethylamine-N-oxide in humans. Nutr Res. 35, 858-864 (2015
35. Boutagy, N. E., et al. Probiotic supplementation and trimethylamine-N-oxide production following a high-fat diet. Obesity (Silver Spring). 23, 2357-2363 (2015
36. Eckel, R. H., et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 63, 2960-2984 (2014
37. Wang, Z., et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell 163, 1585-95 (2015
38. Buscemi, S., et al. Long-term effects of a multidisciplinary treatment of uncomplicated obesity on carotid intima-media thickness. Obesity (Silver Spring) 19, 1187-1192 (2011
39. Dogan, S., Kastelein, J. J., Grobbee, D. E., & Bots, M. L. Mean common or mean maximum carotid intima-media thickness as primary outcome in lipid-modifying intervention studies. J Atheroscler Thromb. 18, 946-957 (2011
40. Stefan, N., & Häring, H. U. The role of hepatokines in metabolism. Nat Rev Endocrinol. 9, 144-152 (2013